Regulation of glucose-6-phosphatase gene expression by insulin and metformin

Hormone and Metabolic Research

Volumn 41, Issue 10, 2009, Pages 730-735

  Mues, C ^a   Zhou, J ^b   Manolopoulos, K N ^c   Korsten, P ^d   Schmoll, D ^e   Klotz, L O ^f   Bornstein, S R ^g   Klein, H H ^a   Barthel, A ^g,h  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b ZHEJIANG UNIVERSITY   (China)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^h Endokrinologikum Ruhr   (Germany)

Author keywords

Diabetes mellitus type 2; Gluconeogenesis; Hepatic glucose production

Indexed keywords

CYCLIC AMP; DEXAMETHASONE; GLUCOSE 6 PHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; MESSENGER RNA; METFORMIN; PROTEIN KINASE B; SERINE; TYROSINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REGULATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GLUCONEOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSE-6-PHOSPHATASE; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 70350361190     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1225360     Document Type: Article

References (31)

1. Schwarz PE, Reimann M, Li J, Bergmann A, Licinio J, Wong ML, Bornstein SR. The Metabolic Syndrome a global challenge for prevention. Horm Metab Res 2007 39 777-780
2. Schwarz PE, Bornstein SR, Hanefeld M. The future of the metabolic syndrome. Horm Metab Res 2009 41 73-74
3. Reimann M, Bonifacio E, Solimena M, Schwarz PE, Ludwig B, Hanefeld M, Bornstein SR. An update on preventive and regenerative therapies in diabetes mellitus. Pharmacol Ther 2009 121 317-331
4. Schinner S, Scherbaum WA, Bornstein SR, Barthel A. Molecular mechanisms of insulin resistance. Diabet Med 2005 22 674-682
5. Barthel A, Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 2003 285 E685-E692
6. Barthel A, Schmoll D, Unterman TG. FoxO proteins in insulin action and metabolism. Trends in endocrinology and metabolism. TEM 2005 16 183-189
7. Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Annu Rev Nutr 1999 19 379-406
8. Schmoll D, Walker KS, Alessi DR, Grempler R, Burchell A, Guo S, Walther R, Unterman TG. Regulation of glucose-6-phosphatase gene expression by protein kinase Balpha and the forkhead transcription factor FKHR. Evidence for insulin response unit-dependent and -independent effects of insulin on promoter activity. J Biol Chem 2000 275 36324-36333
9. Barthel A, Herzig S, Muller HW, Harborth J, Bornstein SR. RNA interference-based strategies for metabolic syndrome treatment. Horm Metab Res 2005 37 59-62
10. Magalhaes FO, Gouveia LM, Torquato MT, Paccola GM, Piccinato CE, Foss MC. Metformin increases blood flow and forearm glucose uptake in a group of non-obese type 2 diabetes patients. Horm Metab Res 2006 38 513-517
11. Ou HY, Cheng JT, Yu EH, Wu TJ. Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects. Horm Metab Res 2006 38 106-111
12. Hundal RS, Krssak M, Dufour S, Laurent D, Lebon V, Chandramouli V, Inzucchi SE, Schumann WC, Petersen KF, Landau BR, Shulman GI. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 2000 49 2063-2069
13. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995 333 550-554
14. Morioka K, Nakatani K, Matsumoto K, Urakawa H, Kitagawa N, Katsuki A, Hori Y, Gabazza EC, Yano Y, Nishioka J, Nobori T, Sumida Y, Adachi Y. Metformin-induced suppression of glucose-6-phosphatase expression is independent of insulin signaling in rat hepatoma cells. Int J Mol Med 2005 15 449-452
15. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001 108 1167-1174
16. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 2007 100 328-341
17. Barthel A, Schmoll D, Kruger KD, Roth RA, Joost HG. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 2002 143 3183-3186
18. Lochhead PA, Salt IP, Walker KS, Hardie DG, Sutherland C. 5-aminoimidazole-4-carboxamide riboside mimics the effects of insulin on the expression of the 2 key gluconeogenic genes PEPCK and glucose-6-phosphatase. Diabetes 2000 49 896-903
19. Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet 1996 30 359-371
20. Kefas BA, Cai Y, Kerckhofs K, Ling Z, Martens G, Heimberg H, Pipeleers D, Van de Casteele M. Metformin-induced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem Pharmacol 2004 68 409-416
21. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000 6 87-97
22. Lamers WH, Hanson RW, Meisner HM. cAMP stimulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase in rat liver nuclei. Proc Natl Acad Sci USA 1982 79 5137-5141
23. Lange AJ, Argaud D, el-Maghrabi MR, Pan W, Maitra SR, Pilkis SJ. Isolation of a cDNA for the catalytic subunit of rat liver glucose-6- phosphatase: regulation of gene expression in FAO hepatoma cells by insulin, dexamethasone and cAMP. Biochem Biophys Res Commun 1994 201 302-309
24. Schmoll D, Wasner C, Hinds CJ, Allan BB, Walther R, Burchell A. Identification of a cAMP response element within the glucose- 6-phosphatase hydrolytic subunit gene promoter which is involved in the transcriptional regulation by cAMP and glucocorticoids in H4IIE hepatoma cells. Biochem J 1999 338 (Pt 2) 457-463
25. Ellis L, Clauser E, Morgan DO, Edery M, Roth RA, Rutter WJ. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 1986 45 721-732
26. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 1996 15 6541-6551
27. Winder WW, Hardie DG. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 1999 277 E1-E10
28. Stein SC, Woods A, Jones NA, Davison MD, Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 2000 345 (Pt 3) 437-443
29. Hundal RS, Inzucchi SE. Metformin: new understandings, new uses. Drugs 2003 63 1879-1894
30. Grempler R, Gunther S, Steffensen KR, Nilsson M, Barthel A, Schmoll D, Walther R. Evidence for an indirect transcriptional regulation of glucose-6-phosphatase gene expression by liver X receptors. Biochem Biophys Res Commun 2005 338 981-986
31. Grempler R, Kienitz A, Werner T, Meyer M, Barthel A, Ailett F, Sutherland C, Walther R, Schmoll D. Tumour necrosis factor alpha decreases glucose-6-phosphatase gene expression by activation of nuclear factor kappaB. Biochem J 2004 382 471-479